|
EAST RUTHERFORD, N.J., Feb. 19, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) and Snapdragon Chemistry, a Cambrex company, are proud to announce that Dr. Song Lin, Tisch University Professor in chemistry and chemical biology at Cornell University's College of Arts and Sciences, has been awarded the 2025 Snapdragon Prize for Innovation in Chemistry Technology, which includes a $50,000 unrestricted fund for the Lin Lab.
Professor Lin is being honored for his pioneering research in electrosynthetic chemistry, which has opened new avenues for the use of electrochemistry in pharmaceutical development and manufacturing. His laboratory focuses on advancing organic chemistry, electrosynthesis, catalysis, and technology development. Professor Lin's recent advancements in sustainable electrochemical techniques for synthesizing complex organic molecules, including chiral compounds critical to pharmaceutical innovation, have set new standards for efficiency and environmental responsibility in the field.
"Cambrex is dedicated to advancing the frontiers of pharmaceutical science through innovation and partnership," said Matthew Bio, Chief Scientific Officer at Cambrex. "Professor Lin's groundbreaking work in electrosynthetic chemistry exemplifies the spirit of the Snapdragon Prize and our commitment to supporting transformative research that will shape the future of drug discovery and manufacturing."
Among his many accolades, Professor Lin is a 2025 Blavatnik National Awards finalist, a 2023 Arthur C. Cope Scholar Award recipient, a 2025 Highly Cited Researcher by Clarivate, and a 2022 Green Chemistry Challenge Award winner. These honors reflect his leadership and sustained impact on the scientific community.
Established in 2024 by Snapdragon Chemistry, the Snapdragon Prize recognizes one leading academic researcher annually in synthetic chemistry or engineering whose work has the potential to significantly impact pharmaceutical discovery and manufacturing, and was previously awarded to Princeton Professor Todd Hyster and the Hyster Lab. This prestigious award underscores Cambrex's commitment to scientific excellence and innovation in complex small molecule development, supporting the next generation of breakthroughs in pharmaceutical science.
About Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services.
With over 45 years of experience and a team of 2,000 experts servicing global clients from North America and Europe, Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, peptide synthesis, solid-state science, material characterization, and highly potent APIs.
EAST RUTHERFORD, N.J., Feb. 19, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) and Snapdragon Chemistry, a Cambrex company, are proud to announce that Dr. Song Lin, Tisch University Professor in chemistry and chemical biology at Cornell University's College of Arts and Sciences, has been awarded the 2025 Snapdragon Prize for Innovation in Chemistry Technology, which includes a $50,000 unrestricted fund for the Lin Lab.
Professor Lin is being honored for his pioneering research in electrosynthetic chemistry, which has opened new avenues for the use of electrochemistry in pharmaceutical development and manufacturing. His laboratory focuses on advancing organic chemistry, electrosynthesis, catalysis, and technology development. Professor Lin's recent advancements in sustainable electrochemical techniques for synthesizing complex organic molecules, including chiral compounds critical to pharmaceutical innovation, have set new standards for efficiency and environmental responsibility in the field.
"Cambrex is dedicated to advancing the frontiers of pharmaceutical science through innovation and partnership," said Matthew Bio, Chief Scientific Officer at Cambrex. "Professor Lin's groundbreaking work in electrosynthetic chemistry exemplifies the spirit of the Snapdragon Prize and our commitment to supporting transformative research that will shape the future of drug discovery and manufacturing."
Among his many accolades, Professor Lin is a 2025 Blavatnik National Awards finalist, a 2023 Arthur C. Cope Scholar Award recipient, a 2025 Highly Cited Researcher by Clarivate, and a 2022 Green Chemistry Challenge Award winner. These honors reflect his leadership and sustained impact on the scientific community.
Established in 2024 by Snapdragon Chemistry, the Snapdragon Prize recognizes one leading academic researcher annually in synthetic chemistry or engineering whose work has the potential to significantly impact pharmaceutical discovery and manufacturing, and was previously awarded to Princeton Professor Todd Hyster and the Hyster Lab. This prestigious award underscores Cambrex's commitment to scientific excellence and innovation in complex small molecule development, supporting the next generation of breakthroughs in pharmaceutical science.
About Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services.
With over 45 years of experience and a team of 2,000 experts servicing global clients from North America and Europe, Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, peptide synthesis, solid-state science, material characterization, and highly potent APIs.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Cambrex Announces Cornell Professor Song Lin as Recipient of the 2025 Snapdragon Prize for Innovation in Chemistry Technology
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- MOMOTOY, a creative platform integrating artificial intelligence, original intellectual property (IP) and youth culture, today announced its official entry into the U.S. market with its debut at Toy Fair New York, held at the Javits Center.
Fresh off its high-profile appearance at China's Spring Festival Gala, MOMOTOY brought its AI-powered storytelling to the global stage. The golden DUNDUN Hidden Figure, which previously sparked viral buzz, also made its U.S. debut.
At the show, MOMOTOY presented its growing portfolio of original IPs—including DUNDUN FAMILY, Pear-Us, The Seedverse and The Soft Forest Tales—drawing strong interest from global buyers, media and pop culture tastemakers. The debut marks a significant milestone in MOMOTOY's global expansion and reinforces its positioning as an AI-driven, next-generation art toy company.
MOMOTOY's differentiation lies in its deep integration of artificial intelligence into physical collectibles. Powered by emotion recognition, voice interaction and affective computing, MOMOTOY's smart toys can sense user emotions, respond to voice commands and engage in multi-language conversations. Features such as voice cloning and character customization transform each product into a personalized "exclusive companion," enabling long-term emotional connection and recurring engagement. MOMOTOY differentiates itself through deep integration of artificial intelligence into physical collectibles.
At Booth #6760, DUNDUN FAMILY emerged as the undisputed crowd favorite. As one of MOMOTOY's flagship IPs, these huggable characters originate from Fluffy Valley, a whimsical realm where dreams meet reality. The booth also showcased Pear-Us, The Seedverse and The Soft Forest Tales, highlighting MOMOTOY's diverse creative universe. Also generating strong buzz was the DUNDUN Gold Hidden Figure, cast in 99.9% pure gold and slated to roll out as an ongoing collector series across multiple IP lines.
MOMOTOY's original IP lineup and AI-enabled products drew sustained attention from North American and European buyers, with multiple products generating interest for bulk purchases. Collectively, these engagements translated into multi-million-dollar qualified sales leads, providing early commercial validation for MOMOTOY's U.S. market entry.
During Toy Fair New York, MOMOTOY officially launched its Global Young Artists Incubation Program, a three-tier initiative offering limited-edition reproductions, revenue-sharing co-creation projects, and scholarships with long-term support for visionary creators. The program received strong interest from emerging artists worldwide, with a notable number of submissions coming from professional art institutions, signaling MOMOTOY's evolution from IP operator into a creator platform.
MOMOTOY views the U.S. as a critical pillar of its globalization strategy. Following a Super Bowl weekend pop-up, the company will host its first U.S. brand event in March 2026 and open its inaugural North American flagship store. As a first-time exhibitor, MOMOTOY showcased alongside global industry leaders including Mattel, LEGO and Funko.
About MOMOTOY
MOMOTOY is a pioneer in global trend culture, headquartered in China with a global outlook. Founded by young designers and technologists, the company integrates full-chain IP operations with advanced AI interaction and affective computing to build a scalable platform for next-generation creative expression.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
MOMOTOY Enters U.S. Market at Toy Fair New York, Advances AI-Driven Art Toy Platform and 2026 Retail Roadmap
